Humatica advises Capvis on their recent investment in AMANN GIRRBACH

ndetails

Humatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm is a leading innovator in the field and a full-service provider for digital dental prosthetics.

Humatica provided organisational due diligence services for this transaction.

To view press release: Humatica advises Capvis on their recent investment in AMANN GIRRBACH

Related News

Humatica finalist for two prestigious PE Awards
16 Jan., 2026 By Humatica

Humatica finalist for two prestigious PE Awards

Humatica is once again shortlisted for Real Deals’ prestigious Private Equity Awards 2026 in the “Value Creation Adviser of the Year” category. This recognition underscores…

Read more arrowicon
Humatica is a Great Place to Work™ – we are officially accredited once again!
06 Jan., 2026 By Humatica

Humatica is a Great Place to Work™ – we are officially accredited once again!

London, January 2026 – Humatica, an award winning leader in organizational transformation for Private Equity, has been officially accredited as a Great Place to Work…

Read more arrowicon
Humatica announces promotions in London
28 Okt., 2025 By Humatica

Humatica announces promotions in London

Humatica is pleased to announce three promotions in its London office. Stephanie Hilders and Richard Breitschwerdt have been promoted to Consultant, and Juan Zapardiel has…

Read more arrowicon